GM

Gollust Management

Description

Gollust Management

Investor Profile

Gollust Management has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gollust Management frequently co-invest with?

MT
North America, California, United States, Los Angeles
Co-Investments: 1
S
North America, Texas, United States, Amarillo
Co-Investments: 1
Caxton Associates
North America, New York, United States, New York
Co-Investments: 1
Galleon Group
North America, New York, United States, New York
Co-Investments: 1
DC
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Gollust Management?

Synta Pharmaceuticals

Lexington, Massachusetts, United States

Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series CJan 14, 2004
Amount Raised: $50,000,000